According to recent data, health expenditures in the U.S. reached $5.3 trillion in 2024. That figure equates to 18% of GDP, and is double what is spent on average in other developed countries. Americans are feeling the pinch, and an estimated 100 million individuals in the country have medical debt.
This situation is unsustainable. While there is broad agreement that the health care system is in crisis, there are sharp divides on what solutions need to be implemented to fix the skyrocketing cost of health care in the U.S. Jordan Bruneau, the Great Lakes Policy Institute’s director, offers some recommendations that Americans themselves can implement without waiting for lawmakers and other policymakers to act on this situation.
He suggests that Americans should demand for transparency in the way health care prices are determined. For example, patients need to demand for upfront pricing of all health care services so that they can know what each provider quotes for a given service. This will help patients identify cases in which prices vary without justification and enable people to choose affordably priced care.
He adds that price transparency will create competition and eliminate the current practice where providers and insurers can charge whatever fees they want without explaining anything to their clients.
Bruneau also recommends that employers demand for access to claims data related to the people they provide health insurance cover for. This data would help to expose incidences of spread pricing within the health insurance industry. This concern isn’t unfounded because an investigation conducted by the New York Times in 2024 found that payment claims sent to employers were often double what the actual cost paid to a provider was. These inflated claims covered the commissions given to middlemen within the health care industry.
When these phantom costs are brought into the open, it will be easier to drive them down or even eliminate them so that the premiums that people pay can come down, Bruneau says.
Bruneau asserts that once employers and individuals push insurers to be transparent on matters of pricing, health care will become similar to other services like auto insurance and plastic surgery where people have sufficient information to enable them make an informed decision about which provider to choose and what they will get as a result of that choice.
Given that health insurance premiums have significantly increased this year after lawmakers failed to extend the ACA tax credits, all stakeholders need to work together to find a lasting solution to the ballooning cost of health care in the country. Otherwise, entities like Astiva Health have little they can do on their own without broader systemic reforms.
About BioMedWire
BioMedWire (“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed) and Life Sciences sectors. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled recognition and brand awareness.
BMW is where breaking news, insightful content and actionable information converge.
To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer
BioMedWire
San Francisco, CA
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com
BioMedWire is powered by IBN
Although CTCL may progress slowly in its early stages, it remains a chronic and ultimately…
The World Health Organization’s recent recognition of rare diseases as a global health priority underscores…
Researchers at the University of Chicago have identified a compound that has shown efficacy in shrinking tumors in…
Scientists have found that keeping circadian rhythms, the variations in body processes during the course…
While many capitalization structures are diluted in the landscape of over-the-counter (“OTC”) markets, Earth Science…
The United States has formally communicated its immediate withdrawal from the World Health Organization (WHO), denying…